Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on May 6, 2024, covering events occurring on May 3, 2024. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of three new independent directors to the Board of Directors:
- Steven E. Abelman: Appointed May 3, 2024. Brings over 30 years of commercial litigation experience, specializing in bankruptcy, creditors' rights, and distressed asset sales.
- Donald F. Browne, C.P.A.: Appointed May 3, 2024. Brings extensive experience in business accounting, financial reporting, and tax audits.
- Chris Baer: Appointed May 2, 2024 (announced previously).
All three directors qualify as independent under NASDAQ Listing Rules. There are no disclosed compensatory arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors. The Company issued a press release on May 3, 2024, announcing the fully constituted Board, which is filed as Exhibit 99.1.
Investor Verification Checklist
- Verify the correct registrant name is BioSig Technologies, Inc. (BSGM), not Streamex Corp.
- Confirm the independence status of the new directors (Abelman, Browne, Baer) per NASDAQ Rule 5605(a)(2).
- Review the attached press release (Exhibit 99.1) for additional context on the Board's strategic direction.
- Note that no financial data is included in this specific filing; refer to recent 10-Q or 10-K filings for financial metrics.